Connection

EDWARD MASON to Anti-Bacterial Agents

This is a "connection" page, showing publications EDWARD MASON has written about Anti-Bacterial Agents.
Connection Strength

1.782
  1. Decreased susceptibilities to Retapamulin, Mupirocin, and Chlorhexidine among Staphylococcus aureus isolates causing skin and soft tissue infections in otherwise healthy children. Antimicrob Agents Chemother. 2014 May; 58(5):2878-83.
    View in: PubMed
    Score: 0.191
  2. Mupirocin resistance in Staphylococcus aureus causing recurrent skin and soft tissue infections in children. Antimicrob Agents Chemother. 2011 May; 55(5):2431-3.
    View in: PubMed
    Score: 0.154
  3. Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric population since 2005. J Clin Microbiol. 2009 Jun; 47(6):1628-30.
    View in: PubMed
    Score: 0.137
  4. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes. Pediatr Infect Dis J. 2003 Jul; 22(7):623-7.
    View in: PubMed
    Score: 0.091
  5. In vitro activities of cethromycin (ABT-773), a new ketolide, against Streptococcus pneumoniae strains that are not susceptible to penicillin or macrolides. Antimicrob Agents Chemother. 2003 Jan; 47(1):166-9.
    View in: PubMed
    Score: 0.088
  6. Streptococcus pneumoniae in the USA: in vitro susceptibility and pharmacodynamic analysis. J Antimicrob Chemother. 2000 May; 45(5):623-31.
    View in: PubMed
    Score: 0.073
  7. Management of infections due to antibiotic-resistant Streptococcus pneumoniae. Clin Microbiol Rev. 1998 Oct; 11(4):628-44.
    View in: PubMed
    Score: 0.066
  8. Invasive pneumococcal infections in children following transplantation in the pneumococcal conjugate vaccine era. Transpl Infect Dis. 2017 Feb; 19(1).
    View in: PubMed
    Score: 0.058
  9. Discrepancies between results by E-test and standard microbroth dilution testing of Streptococcus pneumoniae for susceptibility to vancomycin. J Clin Microbiol. 1996 Jun; 34(6):1546-7.
    View in: PubMed
    Score: 0.056
  10. In vitro activities of oxazolidinones U-100592 and U-100766 against penicillin-resistant and cephalosporin-resistant strains of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1996 Apr; 40(4):1039-40.
    View in: PubMed
    Score: 0.055
  11. Distribution of Streptococcus pneumoniae resistant to penicillin in the USA and in-vitro susceptibility to selected oral antibiotics. J Antimicrob Chemother. 1995 Dec; 36(6):1043-8.
    View in: PubMed
    Score: 0.054
  12. Antimicrobial agents: resistance patterns of common pathogens. Pediatr Infect Dis J. 1994 Nov; 13(11):1050-3.
    View in: PubMed
    Score: 0.050
  13. Staphylococcus aureus infections in pediatric oncology patients: high rates of antimicrobial resistance, antiseptic tolerance and complications. Pediatr Infect Dis J. 2013 Feb; 32(2):124-8.
    View in: PubMed
    Score: 0.044
  14. Increased rate of isolation of penicillin-resistant Streptococcus pneumoniae in a children's hospital and in vitro susceptibilities to antibiotics of potential therapeutic use. Antimicrob Agents Chemother. 1992 Aug; 36(8):1703-7.
    View in: PubMed
    Score: 0.043
  15. Effect of dexamethasone or HWA-138 in combination with antibiotics in experimental Haemophilus influenzae type b infection. Antimicrob Agents Chemother. 1991 Oct; 35(10):1980-4.
    View in: PubMed
    Score: 0.040
  16. Increase in prevalence of Streptococcus pneumoniae serotype 6C at Eight Children's Hospitals in the United States from 1993 to 2009. J Clin Microbiol. 2011 Jun; 49(6):2097-101.
    View in: PubMed
    Score: 0.039
  17. A preliminary report of ticarcillin and clavulanate versus triple antibiotic therapy in children with ruptured appendicitis. Surg Gynecol Obstet. 1991; 172 Suppl:54-6.
    View in: PubMed
    Score: 0.038
  18. Increase of the USA300 clone among community-acquired methicillin-susceptible Staphylococcus aureus causing invasive infections. Pediatr Infect Dis J. 2007 Dec; 26(12):1122-7.
    View in: PubMed
    Score: 0.031
  19. Recurrent systemic pneumococcal disease in children. Pediatr Infect Dis J. 2007 Jun; 26(6):480-4.
    View in: PubMed
    Score: 0.030
  20. Penicillin resistance and serotypes/serogroups of Streptococcus pneumoniae in nasopharyngeal carrier children younger than 2 years in Lima, Peru. Diagn Microbiol Infect Dis. 2005 May; 52(1):59-64.
    View in: PubMed
    Score: 0.026
  21. Azithromycin compared with beta-lactam antibiotic treatment failures in pneumococcal infections of children. Pediatr Infect Dis J. 2004 May; 23(5):399-405.
    View in: PubMed
    Score: 0.024
  22. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J. 2002 Oct; 21(10):910-7.
    View in: PubMed
    Score: 0.022
  23. In vitro activities of the oxazolidinone compounds linezolid (PNU-100766) and eperzolid (PNU-100592) against middle ear isolates of Streptococcus pneumoniae. Int J Antimicrob Agents. 1999 Jul; 12(2):141-4.
    View in: PubMed
    Score: 0.017
  24. Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae. Pediatrics. 1998 Dec; 102(6):1369-75.
    View in: PubMed
    Score: 0.017
  25. Pediatric pneumococcal bone and joint infections. The Pediatric Multicenter Pneumococcal Surveillance Study Group (PMPSSG). Pediatrics. 1998 Dec; 102(6):1376-82.
    View in: PubMed
    Score: 0.017
  26. Molecular Characterization of Staphylococcus aureus Isolates From Children With Periorbital or Orbital Cellulitis. J Pediatric Infect Dis Soc. 2018 Aug 17; 7(3):205-209.
    View in: PubMed
    Score: 0.016
  27. Invasive Serotype 35B Pneumococci Including an Expanding Serotype Switch Lineage. Emerg Infect Dis. 2018 02; 24(2):405.
    View in: PubMed
    Score: 0.016
  28. Osteoarticular Infections Caused by Streptococcus pneumoniae in Children in the Post-Pneumococcal Conjugate Vaccine Era. Pediatr Infect Dis J. 2017 Dec; 36(12):1201-1204.
    View in: PubMed
    Score: 0.015
  29. Staphylococcus aureus Central Nervous System Infections in Children. Pediatr Infect Dis J. 2017 Oct; 36(10):947-951.
    View in: PubMed
    Score: 0.015
  30. Role of Operative or Interventional Radiology-Guided Cultures for Osteomyelitis. Pediatrics. 2016 05; 137(5).
    View in: PubMed
    Score: 0.014
  31. Healthcare-associated Staphylococcus aureus Bacteremia in Children: Evidence for Reverse Vancomycin Creep and Impact of Vancomycin Trough Values on Outcome. Pediatr Infect Dis J. 2016 Mar; 35(3):263-8.
    View in: PubMed
    Score: 0.014
  32. Characterization of Staphylococcus aureus infections in children with Down syndrome. J Infect Chemother. 2015 Nov; 21(11):790-4.
    View in: PubMed
    Score: 0.013
  33. Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in US Children. Clin Infect Dis. 2015 Sep 01; 61(5):767-75.
    View in: PubMed
    Score: 0.013
  34. Antimicrobial activities of beta-lactam antibiotics and gentamicin against penicillin-susceptible and penicillin-resistant pneumococci. Antimicrob Agents Chemother. 1995 May; 39(5):1166-8.
    View in: PubMed
    Score: 0.013
  35. Impact of the 13-valent pneumococcal conjugate vaccine on chronic sinusitis associated with Streptococcus pneumoniae in children. Pediatr Infect Dis J. 2014 Oct; 33(10):1033-6.
    View in: PubMed
    Score: 0.012
  36. Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. Pediatr Infect Dis J. 1994 Jul; 13(7):585-9.
    View in: PubMed
    Score: 0.012
  37. Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins. Antimicrob Agents Chemother. 1994 May; 38(5):918-23.
    View in: PubMed
    Score: 0.012
  38. Community-associated Staphylococcus aureus infections in otherwise healthy infants less than 60 days old. Pediatr Infect Dis J. 2014 Jan; 33(1):98-100.
    View in: PubMed
    Score: 0.012
  39. Changes in Streptococcus pneumoniae serotype 19A invasive infections in children from 1993 to 2011. J Clin Microbiol. 2013 Apr; 51(4):1294-7.
    View in: PubMed
    Score: 0.011
  40. Characterization of nontypeable and atypical Streptococcus pneumoniae pediatric isolates from 1994 to 2010. J Clin Microbiol. 2012 Apr; 50(4):1326-30.
    View in: PubMed
    Score: 0.010
  41. Staphylococcus aureus pneumonia in children in the era of community-acquired methicillin-resistance at Texas Children's Hospital. Pediatr Infect Dis J. 2011 Jul; 30(7):545-50.
    View in: PubMed
    Score: 0.010
  42. Staphylococcus aureus sinus infections in children. Int J Pediatr Otorhinolaryngol. 2011 Jan; 75(1):118-21.
    View in: PubMed
    Score: 0.009
  43. Clinical and molecular epidemiology of Staphylococcus aureus catheter-related bacteremia in children. Pediatr Infect Dis J. 2010 May; 29(5):410-4.
    View in: PubMed
    Score: 0.009
  44. Hospital-acquired Staphylococcus aureus infections at Texas Children's Hospital, 2001-2007. Infect Control Hosp Epidemiol. 2010 Feb; 31(2):183-90.
    View in: PubMed
    Score: 0.009
  45. Serotype 19A is the most common Streptococcus pneumoniae isolate in children with chronic sinusitis. Pediatr Infect Dis J. 2009 Sep; 28(9):766-8.
    View in: PubMed
    Score: 0.009
  46. Subtle genetic changes enhance virulence of methicillin resistant and sensitive Staphylococcus aureus. BMC Microbiol. 2007 Nov 06; 7:99.
    View in: PubMed
    Score: 0.008
  47. Evaluation and treatment of community-acquired Staphylococcus aureus infections in term and late-preterm previously healthy neonates. Pediatrics. 2007 Nov; 120(5):937-45.
    View in: PubMed
    Score: 0.008
  48. Comparative in-vitro activity of LY146032 and eight other antibiotics against gram-positive bacteria isolated from children. J Antimicrob Chemother. 1987 Aug; 20(2):203-7.
    View in: PubMed
    Score: 0.008
  49. Three-year surveillance of community onset health care-associated staphylococcus aureus infections in children. Pediatr Infect Dis J. 2006 Apr; 25(4):349-53.
    View in: PubMed
    Score: 0.007
  50. Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics. 2005 Mar; 115(3):642-8.
    View in: PubMed
    Score: 0.006
  51. Pneumococcal endocarditis in children. Clin Infect Dis. 2004 May 01; 38(9):1273-8.
    View in: PubMed
    Score: 0.006
  52. Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics. 2002 Jul; 110(1 Pt 1):1-6.
    View in: PubMed
    Score: 0.005
  53. Pneumococcal infections in children after transplantation. Clin Infect Dis. 2001 Jul 01; 33(1):16-21.
    View in: PubMed
    Score: 0.005
  54. Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriazone in children treated with beta-lactam antibiotics. Pediatr Infect Dis J. 2001 Apr; 20(4):392-6.
    View in: PubMed
    Score: 0.005
  55. Effect of prior antibiotics on the susceptibility of Haemophilus influenzae type b to ampicillin. Pediatrics. 1981 Feb; 67(2):269-71.
    View in: PubMed
    Score: 0.005
  56. Acute otitis media caused by Streptococcus pneumoniae in children's hospitals between 1994 and 1997. Pediatr Infect Dis J. 2001 Jan; 20(1):34-9.
    View in: PubMed
    Score: 0.005
  57. Nonrespiratory Stenotrophomonas maltophilia infection at a children's hospital. Clin Infect Dis. 2000 Dec; 31(6):1321-30.
    View in: PubMed
    Score: 0.005
  58. Systemic infections due to Streptococcus pneumoniae relatively resistant to penicillin in a children's hospital: clinical management and outcome. Pediatrics. 1992 Dec; 90(6):928-33.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.